Legend Biotech Corp. (LEGN)
18.64
-0.55
(-2.87%)
USD |
NASDAQ |
Sep 11, 16:00
18.79
+0.15
(+0.80%)
After-Hours: 06:49
Legend Biotech Price to Book Value : 2.937 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.937 |
| September 10, 2026 | 3.024 |
| September 09, 2026 | 3.138 |
| September 08, 2026 | 3.229 |
| September 04, 2026 | 3.391 |
| September 03, 2026 | 3.427 |
| September 02, 2026 | 3.450 |
| September 01, 2026 | 3.330 |
| August 31, 2026 | 3.275 |
| August 28, 2026 | 3.133 |
| August 27, 2026 | 3.230 |
| August 26, 2026 | 3.259 |
| August 25, 2026 | 3.356 |
| August 24, 2026 | 3.300 |
| August 21, 2026 | 3.438 |
| August 20, 2026 | 3.350 |
| August 19, 2026 | 3.561 |
| August 18, 2026 | 3.454 |
| August 17, 2026 | 3.254 |
| August 14, 2026 | 3.21 |
| August 13, 2026 | 3.194 |
| August 12, 2026 | 3.254 |
| August 11, 2026 | 3.44 |
| August 10, 2026 | 3.256 |
| August 07, 2026 | 3.270 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.038 |
| August 05, 2026 | 3.002 |
| August 04, 2026 | 3.015 |
| August 03, 2026 | 2.996 |
| July 31, 2026 | 2.923 |
| July 30, 2026 | 3.002 |
| July 29, 2026 | 2.970 |
| July 28, 2026 | 3.000 |
| July 27, 2026 | 3.037 |
| July 24, 2026 | 3.502 |
| July 23, 2026 | 3.708 |
| July 22, 2026 | 3.708 |
| July 21, 2026 | 3.710 |
| July 20, 2026 | 3.658 |
| July 17, 2026 | 3.508 |
| July 16, 2026 | 3.579 |
| July 15, 2026 | 3.631 |
| July 14, 2026 | 4.045 |
| July 13, 2026 | 4.058 |
| July 10, 2026 | 4.267 |
| July 09, 2026 | 4.315 |
| July 08, 2026 | 4.392 |
| July 07, 2026 | 4.362 |
| July 06, 2026 | 4.419 |
| July 02, 2026 | 4.713 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Gilead Sciences, Inc. | 15.08 |
| Arbutus Biopharma Corp. | 3.911 |
| AbbVie, Inc. | -- |
| TG Therapeutics, Inc. | 13.66 |
| Capricor Therapeutics, Inc. | 1.975 |
Price to Book Value Related Metrics
| PS Ratio | 2.737 |
| Price | 18.64 |
| Earnings Yield | -2.71% |
| Market Cap | 3.612B |